Skip to content
DefDex

Federal award

SOUTH TEXAS BLOOD & TISSUE CENTER

W81K0018P0426

Contract

Obligated and Ceiling

Obligated (net)
$1,640,327.85
Ceiling (potential value, not spending)
$4,035,398.85
Current value
$4,035,398.85
Gross positive obligations
$2,196,714.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
SOUTH TEXAS BLOOD & TISSUE CENTER · J4UKR8JY4L54
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
SOUTH TEXAS BLOOD & TISSUE CENTER · J4UKR8JY4L54
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
621991 · BLOOD AND ORGAN BANKS
PIID
W81K0018P0426
Award type code
B
Actions
12 · Jul 17, 2018 to Jan 10, 2024
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History12

Award actions
DateFYModAction typeObligationCompany in company totals
Jan 10, 2024FY2024P00011B−$556,386.15
—
Oct 31, 2022FY2023P00010C$1,098,357.00
—
Jul 27, 2022FY2022P00009B$0.00
—
Nov 18, 2021FY2022P00008C$1,098,357.00
—
Jun 8, 2021FY2021P00007G$0.00
—
Nov 5, 2020FY2021P00006C$0.00
—
Oct 30, 2020FY2021P00005M$0.00
—
Aug 30, 2020FY2020P00004G$0.00
—
Nov 29, 2019FY2020P00003C$0.00
—
Jun 6, 2019FY2019P00002G$0.00
—
Oct 2, 2018FY2019P00001C$0.00
—
Jul 17, 2018FY20180—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.